MedPath

Lidocaine

LIDOCAINE OINTMENT USP, 5%

Approved
Approval ID

88ca9cba-0c4a-482f-b502-ceefdb1bfbcd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 7, 2022

Manufacturers
FDA

Fougera Pharmaceuticals Inc.

DUNS: 043838424

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0168-0204
Application NumberANDA080198
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lidocaine
Product Specifications
Route of AdministrationTOPICAL
Effective DateOctober 15, 2011
FDA Product Classification

INGREDIENTS (3)

polyethylene glycol 300Inactive
Code: 5655G9Y8AQ
Classification: IACT
lidocaineActive
Quantity: 50 mg in 1 g
Code: 98PI200987
Classification: ACTIB
polyethylene glycol 1450Inactive
Code: OJ4Z5Z32L4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine - FDA Drug Approval Details